Effectiveness of valganciclovir 900 mg versus 450 mg for cytomegalovirus prophylaxis in transplantation: direct and indirect treatment comparison meta-analysis.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 21189424)

Published in Clin Infect Dis on December 28, 2010

Authors

Andre C Kalil1, Cezarina Mindru, Diana F Florescu

Author Affiliations

1: Infectious Diseases Division, University of Nebraska Medical Center, Omaha, Nebraska 68198-5400, USA. akalil@unmc.edu

Articles by these authors

Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med (2009) 2.65

What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression. Clin Infect Dis (2012) 1.69

Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species. Med Mycol (2012) 1.06

What do we know about adenovirus in renal transplantation? Nephrol Dial Transplant (2013) 0.96

Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis. Crit Care (2013) 0.88

Adenovirus: current epidemiology and emerging approaches to prevention and treatment. Curr Infect Dis Rep (2014) 0.86

The importance of detecting cytomegalovirus infections in studies evaluating new therapies for severe sepsis. Crit Care Med (2010) 0.85

Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis? Crit Care (2011) 0.83

A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation (2015) 0.83

Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis. Hemodial Int (2012) 0.83

Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis. Liver Transpl (2012) 0.81

Risk of serious opportunistic infections after solid organ transplantation: interleukin-2 receptor antagonists versus polyclonal antibodies. A meta-analysis. Expert Rev Anti Infect Ther (2014) 0.80

A retrospective study of bacterial infections in cirrhosis. Maedica (Buchar) (2011) 0.77

Why valganciclovir should not be indicated for liver recipients and high-dose acyclovir should not be removed from international cytomegalovirus guidelines. Transplantation (2011) 0.76

Pediococcus acidilactici endocarditis successfully treated with daptomycin. J Clin Microbiol (2012) 0.75

Can we predict cytomegalovirus reactivation in critically ill patients? Crit Care Med (2012) 0.75

Education and Communication in an Interprofessional Antimicrobial Stewardship Program. J Am Osteopath Assoc (2016) 0.75

Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin. Pediatr Transplant (2012) 0.75

Cytomegalovirus reactivation and colitis after left ventricular assist device placement. Int J Infect Dis (2013) 0.75